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Agrin, through its interaction with the receptor
tyrosine kinase MuSK, mediates accumulation
of acetylcholine receptors (AChR) at the devel-
oping neuromuscular junction. Agrin has also
been implicated in several functions in brain.
However, the mechanism by which agrin exerts
its effects in neural tissue is unknown. Here we
present biochemical evidence that agrin binds
to the a3 subunit of the Na+/K+-ATPase (NKA)
in CNS neurons. Colocalization with agrin bind-
ing sites at synapses supports the hypothesis
that the a3NKA is a neuronal agrin receptor.
Agrin inhibition of a3NKA activity results in
membrane depolarization and increased action
potential frequency in cortical neurons in cul-
ture and acute slice. An agrin fragment that
acts as a competitive antagonist depresses ac-
tion potential frequency, showing that endoge-
nous agrin regulates native a3NKA function.
These data demonstrate that, through its inter-
action with the a3NKA, agrin regulates activity-
dependent processes in neurons, providing a
molecular framework for agrin action in the CNS.
INTRODUCTION
Agrin, a heparan sulfate proteoglycan, was originally iso-
lated from the electric organs of marine rays based on its
ability to induce the formation of high-density clusters of
acetylcholine receptors (AChR) on the surface of cultured
muscle cells (Nitkin et al., 1987). It is present at the earliest
nerve-muscle contacts during development (Fallon et al.,
1985) and, in mature muscles, is localized to the synaptic
basal lamina that lies between the axon terminal and mus-
cle fiber (Reist et al., 1987). Agrin is synthesized by motor
neurons and antibodies against agrin block formation of
motor neuron-induced clusters of AChR on cultured mus-
cle cells (Reist et al., 1992). When expressed in muscle fi-
bers in vivo, agrin induces formation of ectopic postsynap-tic structures (Cohen et al., 1997a), whereas mutation of
theAgrn gene blocks accumulation of AChR at developing
neuromuscular junctions (Gautam et al., 1996). Thus, agrin
is both sufficient and necessary for differentiation of the
postsynaptic apparatus of the neuromuscular junction.
Much of what is known about agrin function at the neu-
romuscular junction has come from studies of the cell sur-
facemolecules with which it interacts. For example, a lam-
inin binding domain at agrin’s NH2 terminus anchors agrin
to the basal lamina (Denzer et al., 1997), while binding to
a-dystroglycan provides a structural link to the muscle-
fiber cytoskeleton that may stabilize the postsynaptic ap-
paratus (Cote et al., 1999). It is the receptor tyrosine kinase
MuSK, however, that is responsible for agrin-induced
clustering of AChR. MuSK is concentrated in the postsyn-
aptic muscle-fiber membrane (Valenzuela et al., 1995) and
is rapidly phosphorylated in the presence of ‘‘active’’
agrin, which includes either one or two alternatively
spliced exons at the z site (z+ agrin), but not the ‘‘inactive’’
isoform, which lacks a z site insert. Inhibition of MuSK
phosphorylation blocks agrin-induced AChR clustering
(Herbst and Burden, 2000), and mice lacking a functional
MuSK gene display a phenotype similar to that of the agrin
mutant (DeChiara et al., 1996).
Several lines of evidence suggest that agrin is also im-
portant for brain development. It is expressed by all pop-
ulations of neurons in brain (O’Connor et al., 1994) and is
concentrated at interneuronal synapses (Mann and Kro¨-
ger, 1996; Hoover et al., 2003). Moreover, the highest
levels of agrin expression in developing brain coincide
with periods of synapse formation (Cohen et al., 1997b;
Li et al., 1997). These observations suggest a function
analogous to its role at the neuromuscular junction, and,
consistent with this hypothesis, synapse formation be-
tween cultured hippocampal neurons is disrupted when
either agrin expression or function is suppressed (Ferreira,
1999; Bo¨se et al., 2000). However, the mechanism by
which agrin exerts its effects in neurons must differ from
that at the neuromuscular junction. First, MuSK expres-
sion is below detection in mammalian brain (Valenzuela
et al., 1995). Second, mutation of the Agrn gene that
blocks expression of z+ agrin and disrupts neuromuscular
synapse formation has no effect on neuron-neuron synap-
togenesis (Li et al., 1999; Serpinskaya et al., 1999).Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc. 359
Figure 1. Agrin Binds to and Induces
Tyrosine Phosphorylation of a 110 kDa
Protein on Neuron Surface Membranes
(A) Immunoblot of cultured cortical cells cross-
linked with BS3 in the presence of either C-
Ag208 or C-Ag15 probed with an antibody to
a myc tag on the agrin fragments, showing
agrin adducts of 130 and 125 kDa in neurons
but not nonneuronal cells.
(B) Agrin adducts were immunoprecipitated
with either an agrin antiserum (Agrin) or an
anti-phosphotyrosine monoclonal antibody
(PY) and then analyzed by immunoblotting for
the myc tag. Crosslinking to C-Ag208 or C-
Ag15 alone results in the appearance of the ap-
propriately sized bands, but only the 125 kDa
band was present when C-Ag208 was cross-
linked in the presence of an excess of C-
Ag15. Phosphorylation of the crosslinked com-
plex is induced by C-Ag208 but not C-Ag15.
Consistent with the competition studies, C-
Ag208-induced phosphorylation of the agrin
adduct is blocked by C-Ag15.However, agrin mutant neurons are resistant to excito-
toxic injury, and heterozygous agrin mutant mice are
less sensitive to systemic treatment with kainic acid (Hil-
genberg et al., 2002), consistent with agrin regulating
some aspect of neuronal activity.
Molecular identification of the receptor that mediates
agrin’s effects in neurons would greatly enhance our un-
derstanding of agrin function in the CNS. Evidence that
such a receptor exists comes from biochemical studies
showing that agrin induces expression of c-fos in cortical
and other CNS neurons (Hilgenberg et al., 1999). Interest-
ingly, signaling by the neuronal agrin receptor shares
some similarity with agrin-induced AChR clustering in
muscle, most notably its Ca2+ dependence and sensitivity
to inhibition of tyrosine kinase activity. However, in con-
trast to AChR clustering, where only z+ agrin is active, z+
and z agrin isoforms are equally potent agonists of the
neuronal agrin receptor (Hilgenberg et al., 1999; Hilgen-
berg and Smith, 2004), evidence that the neuronal recep-
tor is distinct from MuSK. Activation of the agrin receptor
leads to a rapid increase in intracellular Ca2+, which serves
as the initiating event for many of agrin’s effects on neu-
rons (Hilgenberg and Smith, 2004). Consistent with a func-
tion regulating neuronal activity, recent studies using min-
imal fragments of agrin as affinity probes have shown that
a receptor for agrin is concentrated at synaptic sites (Hoo-
ver et al., 2003). Here we show that this neuronal agrin re-
ceptor is a member of the Na+/K+-ATPase (NKA) family of
ion pumps and that agrin binding inhibits pump activity,
modulating membrane potential and action potential fre-
quencies of cortical neurons in vitro and in vivo.
RESULTS
Agrin Binds the a3NKA on Cortical Neurons
Biochemical and Ca2+ imaging studies have provided
evidence for an agrin receptor in cortical and other CNS360 Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc.neurons, distinct from theMuSK/MASC receptor complex
responsible for agrin signaling in skeletal muscle (Hilgen-
berg et al., 1999; Hilgenberg and Smith, 2004). Recently,
we identified a minimal COOH-terminal region of agrin,
C-Ag20, sufficient to activate the neuronal receptor and
a smaller fragment, C-Ag15, which acts as an agrin antag-
onist (Hoover et al., 2003). As a first step toward identifying
the binding site responsible for agrin activity in neurons,
we used the membrane-impermeant bifunctional reagent
bis[sulfosuccinimidyl] suberate (BS3) to chemically cross-
link agrin fragments to components present on the surface
of cells cultured from cerebral cortex. Cell membranes
were then isolated and analyzed by immunoblotting with
a monoclonal antibody (9E10.2, Invitrogen) against a
COOH-terminal myc tag on the recombinant agrin frag-
ments. Crosslinking C-Ag208 or C-Ag15 to cortical neu-
rons resulted in the appearance of clear anti-myc immu-
noreactive bands with apparent molecular weights of
130 and 125 kDa, respectively, much larger than the ex-
pected mass of the agrin fragments (Figure 1A). Agrin nei-
ther binds to nor activates nonneuronal cells (Hilgenberg
et al., 1999; Hoover et al., 2003; Hilgenberg and Smith,
2004). Consistent with this observation, no specific label-
ing with the myc antibody was observed in blots of non-
neuronal cells (Figure 1A). Similar results were obtained
with a second crosslinking agent, dimethyl adipimidate
(DMA), whose reactive groups are more closely spaced
than BS3 (8.6 A˚ versus 11.4 A˚; data not shown). Taking
into account the mass of the agrin fragments and assum-
ing a 1:1 stoichiometry, the results suggest that agrin
associates with a single class of sites, with an apparent
molecular weight of 110 kDa, present on neuron cell
membranes.
Ligand-induced phosphorylation is a common first step
inmembrane receptor activation, and inhibition of tyrosine
kinase activity blocks agrin signaling in CNS neurons (Hil-
genberg et al., 1999; Hilgenberg and Smith, 2004). To
determine whether agrin induces phosphorylation of the
putative agrin receptor, membranes from neurons cross-
linked to C-Ag208 or C-Ag15, either alone or in combina-
tion, were dissolved in a detergent-containing buffer,
and aliquots were immunoprecipitated with either an agrin
antiserum (Hoover et al., 2003) or anti-phosphotyrosine
monoclonal antibody (mAb4G10; Upstate). Immunopre-
cipitated proteins were analyzed by immunoblotting for
the COOH-terminal myc tag on the agrin fragments. In
line with our initial results, anti-agrin immunoprecipitates
probed for myc tagged C-Ag208 or C-Ag15 revealed two
adducts of the expected molecular weight (Figure 1B).
However, only the 130 kDa band crosslinked to C-Ag208
was phosphorylated. Even when used at a 10-fold higher
concentration thanC-Ag208, C-Ag15 did not induce phos-
phorylation of the crosslinked complex. C-Ag15 was,
however, an effective inhibitor of C-Ag208, blocking both
binding and phosphorylation by the larger agrin fragment
(Figure 1B), consistent with its ability to antagonize agrin
signaling.
The properties of the agrin adducts suggest that they
represent a complex of an agrin fragment and a receptor
that mediates responses to agrin in CNS neurons (Hilgen-
berg et al., 1999, 2002; Hoover et al., 2003; Hilgenberg
and Smith, 2004). To determine the molecular identity of
this putative agrin receptor, C-Ag208 adducts, crosslinked
with either BS3 or DMA, were affinity purified, and the
identity of the component proteins was determined by
mass spectrometry of their tryptic digests (Proteomic Re-
search Services, Inc.). In addition to the expected peptide
sequences for agrin, 4 to 12 peptides were present in each
sample thatmatched the a3 subunit of the NKA. Similar re-
sults were also obtained when C-Ag908 (R&D Systems),
a larger COOH-terminal fragment more commonly used
in studies of agrin function, was used in place of C-
Ag208. Combined, the data for the three samples repre-
sented 17% coverage of the a3 subunit amino acid
sequence overall.
To confirm the results of the mass spectrometry, we
tested the ability of different NKA a subunit antibodies
to recognize the putative agrin-a3NKA complex. When
probed with an anti-a3 subunit monoclonal antibody
(XVIF9-G10; Novus Biologicals), immunoblots of cultured
cortical neurons treated with BS3 alone contained a major
110 kDa band corresponding to the a3 subunit (Figure 2A).
Crosslinking in the presence of C-Ag15, C-Ag200, or C-
Ag908 resulted in a3-positive bands at 125, 130, and
200 kDa, respectively, consistent with agrin binding to
the a3 subunit of the NKA. No molecular-weight shift
was apparent when the same cell extracts were probed
with an antibody to the closely related a1NKA (9A-5;
Sigma), showing that agrin binding is specific for the a3
subunit (Figure 2A).
Previous studies have shown that the a3NKA is distrib-
uted in a nonuniform fashion over the soma and processes
of cultured hippocampal neurons (Juhaszova and Blaus-
tein, 1997), reminiscent of the pattern of labeling observed
using short agrin fragments as histochemical probes foragrin receptors on cultured cortical neurons (Hoover
et al., 2003). Double labeling with the a3 subunit monoclo-
nal antibody and C-Ag208 revealed extensive overlap
between the a3NKA and agrin binding sites on cultured
cortical neurons (Figure 2B). Consistent with our earlier
studies (Hoover et al., 2003), double labeling for synapto-
physin and the a3NKA shows agrin receptors diffusely
distributed over the neuronal soma but concentrated at
synapses (Figure 2C). Together with the results of the bio-
chemical studies, these observations provide strong evi-
dence that the a3NKA is a neuronal receptor for agrin.
Agrin Inhibits Activity of the a3NKA
NKAs are heteromeric proteins composed of a and b sub-
units. Multiple isoforms of each subunit are encoded by
different genes that exhibit cell-specific patterns of ex-
pression. Expression of the a3 subunit in the CNS is neu-
ron specific (Kaplan, 2002). Neurons but not nonneuronal
Figure 2. Agrin Binds Specifically to the a3NKA on CNS
Neurons
(A) Blots of naive control cultured cortical neurons (C) and neurons
crosslinked to the indicated agrin fragments (C-Ag15, C-Ag200, and
C-Ag908) were probed with monoclonal antibodies against either the
a3- or a1NKA. Only the a3NKA shows the predicted increases in mo-
lecular weight.
(B) Cortical neuronswere double labeled for a3NKA andC-Ag208 bind-
ing sites. Consistent with the biochemical analysis, agrin binding sites
and a3NKA are colocalized, appearing as small puncta distributed
over the surface of the neuron soma and neurites.
(C) Double labeling with synaptophysin reveals a3NKA concentrated
at synapses. Scale bars = 10 mm.Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc. 361
Figure 3. Agrin Inhibits a3NKA Function
(A) Pseudocolor images of cells loaded with the Na+-sensitive dye SBFI-AM, before (Control) and 90 s after exposure to C-Ag208. Na
+ levels increase
in the neurons (arrows), but not in nonneuronal cells (arrowheads), following agrin treatment. Scale bar = 20 mm.
(B) Treatment with C-Ag208 triggers a rapid increase in neuronal intracellular Na
+ (solid line, arrow in [A]) that returns to initial resting level upon being
washed in normal saline solution (S). The small response in the nonneuronal cell (broken line, arrowhead in [A]) is due to fine neurites traversing the
sampled region.
(C) Neuronal Na+ levels are unchanged following treatment with C-Ag15 alone, but C-Ag15 blocks the large increase induced by C-Ag200.
(D) Treatment with a saturating concentration of either C-Ag20 isoform or C-Ag908 resulted in a significant increase in intracellular Na
+ concentration,
expressed as a percent of the maximal response to gramicidin, that could be blocked by coincubation with C-Ag15.
(E) The increase in neuronal Na+ levels induced by 3 mM ouabain was significantly reduced by coincubation with C-Ag15.
(F) Whole-cell current-clamp record showing reversible membrane depolarization produced in a neuron by treatment with C-Ag208.
(G) Treatment with C-Ag15 resulted in a small hyperpolarization and blocked the change in membrane potential induced by C-Ag200.
(H) Treatment with ‘‘active’’ fragments of agrin causes membrane depolarization, whereas the membrane potentials of cells exposed to C-Ag200 or
C-Ag208 in the presence of C-Ag15 were indistinguishable from their normal resting membrane potentials obtained before treatment (data for
C-Ag200 and C-Ag208 were not different and have been pooled).
(I) Ouabain-induced neuron membrane depolarization is also blocked by C-Ag15. Bars show mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; paired
Student’s t test.cells respond to treatment with agrin, suggesting a role for
agrin in modulating the function of a3 subunit-containing
Na+/K+ pumps. To test this hypothesis, Na+ imaging was
used to determine the effect of agrin on cytoplasmic Na+
levels in cultured cortical cells.
Treatment with C-Ag208, in the presence of tetrodotoxin
(TTX;1mM),6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX;
10 mM), DL-2-amino-5-phosphonovaleric acid (APV; 50
mM), bicucullinemethochloride (BMC; 10 mM), and d-tubo-
curare (dTbC; 100 mM), to block action potentials and syn-
aptic transmission caused a rapid increase in neuronal362 Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc.cytoplasmic Na+. The response to agrin was reversible
and cell specific in that nonneuronal cells were unaffected
by the treatment (Figures 3A and 3B). Consistent with its
ability to bind but not activate the receptor, C-Ag15 alone
had no significant effect on resting Na+ levels but blocked
the increase induced by the larger agrin fragments
(Figure 3C). Quantitative comparison of the effects of dif-
ferent agrin fragments showed that treatment with either
of the alternatively splicedC-Ag20 isoformsorC-Ag908 re-
sulted in a significant increase in neuronal intracellular Na+
(Figure 3D). In contrast, C-Ag15 alone had no effect on
resting Na+ levels but blocked the increase normally in-
duced by each of the active agrin fragments.
Cardiac glycosides, such as ouabain, specifically inhibit
NKA activity by binding to determinants present on the ex-
tracellular surface of the a subunit (Kaplan, 2002). The
short latency of the agrin response (t1/2 to peak = 19.7 ±
2.4 s) suggested that agrin might be inhibiting the
a3NKA in a similar manner. Supporting this hypothesis,
treatment with a low concentration of ouabain to inhibit
the high-affinity a3NKA resulted in an increase in neuronal
Na+ levels similar to that seen following treatment with
active agrin fragments (Figure 3E). Coincubation with
C-Ag15 at the same concentration that blocked binding
of the active agrin fragments also blocked the ouabain-
induced increase in neuronal Na+, providing strong evi-
dence that agrin-induced inhibition of the a3NKA is medi-
ated by binding directly to the a3 subunit.
TheNKA expels three intracellular Na+ ions for every two
K+ ions taken up, directly affecting themembrane potential
of all animal cells. In linewith the results of theNa+ imaging,
whole-cell current-clamp measurements showed that
agrin treatment, in the presence of drugs to block action
potentials and synaptic transmission, causes a rapid and
reversible depolarization of cultured cortical neurons (Fig-
ures 3F and 3H). Moreover, C-Ag15 was also effective in
blocking depolarization induced by the active agrin frag-
ments (Figures 3G and 3H). Interestingly, treatment with
C-Ag15 resulted in a small hyperpolarization (1.0 ±
0.4mV, p < 0.05; Figures 3Gand 3H), suggesting displace-
ment of endogenous agrin. Consistent with the results of
the Na+ imaging, ouabain-induced membrane depolariza-
tion was blocked by C-Ag15 (Figure 3I), confirming that
agrin’s effect on neuron membrane potential is mediated
by its interaction with the a3Na+/K+ pump.
Expression of the a3 Subunit of the NKA Is Sufficient
for Agrin Binding and Agrin-Evoked Responses
Studies of MuSK, the receptor in skeletal muscle respon-
sible for agrin-induced clustering of AChR, have shown
that agrin-MuSK interaction requires a yet to be identified
accessory component expressed only in muscle called
MASC (Glass et al., 1996). To learn whether agrin interac-
tion with the a3NKAmight exhibit a similar dependency on
cell context, we examined the properties of nonneuronal
cells transiently transfected with pRca3, a plasmid ex-
pressing the rat a3 subunit under control of the CMV pro-
moter.
Immunostaining with an antibody to the a3NKA showed
that nonneuronal cells transfected with pRca3, but not
cells transfectedwith the enhanced green fluorescent pro-
tein marker plasmid pEGFP-C1 alone, expressed the a3
subunit (data not shown). In line with these findings, agrin
binding was only observed on the surface membranes of
nonneuronal cells expressing pRca3 (Figure 4A). Immuno-
blots of agrin fragments crosslinked to nonneuronal cells
confirmed the interaction with the a3 subunit expressed
from the transfected plasmid (Figure 4B). Thus, expres-sion of the a3 subunit of the NKA is sufficient for agrin
binding and is independent of cell context.
We next examined the physiological responses of non-
neuronal cells transfected with pRca3 to agrin. Treatment
of nonneuronal cells expressing the a3 subunit with either
C-Ag20 isoform or C-Ag908 triggered a rapid increase in
the concentration of intracellular Na+ ions that was not ev-
ident in normal cells or cells transfected with pEGFP-C1
alone (Figures 4C and 4D). Consistent with our earlier
results, Na+ levels were unaffected by treatment with
C-Ag15 alone, although C-Ag15 proved to be an effective
antagonist for the active agrin fragments (Figure 4D).
Parallel observations were obtained when whole-cell
current-clamp measurements were made to examine the
effects of agrin on the electrophysiological properties of
nonneuronal cells expressing the a3 construct (Figures
4E and 4F). The mean resting potential of nonneuronal
cells was higher and more variable than in neurons. Nev-
ertheless, nonneuronal cells expressing the rat a3NKA
subunit were reversibly depolarized (14.1 ± 1.7 mV) by
treatment with either of the C-Ag20 fragments. In contrast,
no change in the membrane potential was evident upon
agrin treatment of nontransfected nonneuronal cells or
cells transfected with pEGFP-C1 alone (Figure 4F), indi-
cating that the response to agrin was specific for the
pRca3 construct. Taken together, these findings provide
strong evidence that the a3 subunit of the NKA is the re-
ceptor responsible for agrin’s effects in cortical neurons.
Agrin-a3NKA Interactions Regulate
Neuronal Activity In Situ
The electrogenic activity of the NKA and its role in main-
taining gradients of counter-ions necessary for the func-
tion of other transport proteins suggest that changes in
a3NKA activity will have profound effects on neuronal
function and excitability. To test this hypothesis, we ex-
amined the effects of different agrin fragments on the firing
properties of cultured cortical neurons bathed in normal
external solution.
In linewithour earlier observations, neuronswere rapidly
depolarized by treatment with C-Ag200. However, in the
absence of TTX and neurotransmitter receptor antago-
nists, the agrin-induced depolarization was accompanied
by a significant and reversible increase in the frequency
of spontaneous action potentials (Figures 5A and 5B).
Similar results were also obtained when neurons were
exposed to C-Ag208. Coincubation with C-Ag15 blocked
both the depolarization and increase in action potential
frequency induced by either C-Ag20 isoform (data not
shown).
The response to exogenously applied agrin prompted
us to ask whether the basal level of activity normally pres-
ent in cultured neurons might be dependent upon endog-
enous agrin-a3NKA interactions. To address this ques-
tion, we tested the effects of C-Ag15 on spontaneous
action potentials in cultured cortical neurons (Figures 5C
and 5D). In contrast to C-Ag20, C-Ag15 inhibited sponta-
neous activity in cortical neurons. The effect of C-Ag15Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc. 363
Figure 4. Expression of the a3 Subunit
of the NKA in Nonneuronal Cells Confers
Binding and Functional Response to
Agrin
(A) Transfected and nontransfected cells were
visualizedbypostlabeling forGFAP.OnlyEGFP-
positive cells cotransfectedwith pEGFP-C1and
pRca3 bind agrin (C-Ag200). Asterisks indicate
nontransfected cells. Scale bar = 10 mm.
(B) An immunoblot probed with an antibody to
the a3NKA. The a3 subunit is expressed in
transfected (T) but not sham-transfected (S)
control cells and can be crosslinked to agrin.
(C) The DIC image shows a pair of cells in which
only the lower cell has been transfected with
pRca3, indicated by expression of EGFP. The
pseudocolor images show that, compared to
saline control, treatment with C-Ag200 results
in a marked increase in intracellular Na+ con-
centration in the transfected but not the non-
transfected cell. Scale bar = 10 mm.
(D) Bar chart shows mean response to different
agrin fragments of nonneuronal cells trans-
fected with either pEGFP-C1 alone (filled bar)
or in combination with pRca3. Responses of
pEGFP-C1-transfected cells to C-Ag200 and
C-Ag208 have been pooled. Bars show
mean ±SEM. ***p < 0.001; ANOVAwith Bonfer-
roni post hoccomparison topEGFP-C1control.
(E) pRca3 expression in nonneuronal cells con-
fers an agrin-inducible reversible membrane
depolarization that can be blocked by C-Ag15.
(F) Nonneuronal cells expressing the a3 subunit
of the NKA but not control (nontransfected or
pEGFP-C1-transfected) cells are consistently
depolarized (p < 0.001, paired Student’s t test)
by treatment with agrin.was reversible in that the frequency of spontaneous action
potentials returned to basal levels upon washing with nor-
mal external solution (Figure 5C).
A simple explanation for the effect of C-Ag15 on neuro-
nal activity is that some a3NKAs are normally inhibited by
native agrin; competition by C-Ag15 removes this inhibi-
tion, decreasing the probability of firing. Consistent with
this hypothesis, pull-down experiments on detergent ex-
tracts of cultured neurons crosslinked with BS3 revealed
a protein complex with an apparent molecular weight of
R300 kDa recognized by both agrin and a3NKA anti-
bodies (Figure 6A). Moreover, formation of the endoge-
nous agrin-a3NKA complex was blocked by crosslinking
in the presence of C-Ag15, providing evidence that
endogenous agrin can be displaced from its receptor by
C-Ag15. Omission of the crosslinking step in control cul-
tures resulted in the appearance of a 110 kDa band char-
acteristic of the native a3NKA.
Similar results were obtained when the same experi-
mental paradigm was used to crosslink endogenous
agrin-a3NKA complexes in cortical slices prepared from
12-day-old mice (Figure 6A), providing evidence that agrin
might be regulating neuronal activity in vivo. To examine364 Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc.this possibility, we tested the effects of C-Ag20 and
C-Ag15 on the electrophysiological properties of layer V
neurons in acute cortical slices prepared from 6- to
11-day-old mice. Only about 10% of neurons in the slice
preparations exhibited spontaneous action potentials.
Nevertheless, similar to its effects on cultured neurons,
bath application of C-Ag200 resulted in rapid depolariza-
tion (D9.6 ± 2.22 mV, p < 0.001, paired Student’s t test)
and appearance of high-frequency action potentials
(Figures 6B and 6C). In line with the results on cultured
neurons, the response to C-Ag200 was also blocked by
C-Ag15 (data not shown), arguing that the effect of agrin
is specifically mediated through inhibition of the a3NKA.
The low frequency of spontaneously active neurons in
the cortical slices limited our ability to examine the effects
of C-Ag15 on ongoing activity, but C-Ag15 reversibly in-
hibited action potentials in two neurons that were found
to be spontaneously active (data not shown). For a more
robust test of the role of endogenous agrin in regulating
neuronal activity, we examined the ability of C-Ag15 to in-
hibit action potentials induced by the glutamate-receptor
agonist kainic acid. As expected, treatment with kainic
acid (0.5 mM) induced a rapid depolarization accompanied
by the appearance of sustained high-frequency action po-
tentials in most neurons (Figures 6D and 6E). However,
within 10min of the addition of C-Ag15, neuronmembrane
potentials became increasingly more negative to a point
where they were comparable to normal resting membrane
potentialsmeasured prior to kainic acid/C-Ag15 treatment
(56.2 ± 1.3 mV in kainic acid versus 66.3 ± 1.8 mV in
kainic acid + C-Ag15, p < 0.01, paired Student’s t test;
70.4 ± 1.6 mV in saline). Action potential frequency
also declined over a similar time course, from a mean of
0.6 ± 0.2 Hz in kainic acid to 0.01 ± 0.005 Hz in kainic
acid + C-Ag15. The fact that C-Ag15’s effects on mem-
brane potential and action potential frequency were re-
versible is evidence of the specificity of C-Ag15 action.
DISCUSSION
Agrin has been implicated in a wide range of functions in
central and peripheral neurons, including organization of
pre- and postsynaptic specializations, process growth,
calcium homeostasis, and now neuronal activity. How-
ever, a general mechanism of agrin action has been elu-
sive, in large part due to a lack of knowledge concerning
Figure 5. Frequency of Spontaneous Action Potentials in Cul-
tured Neurons Is Agrin Dependent
(A) A typical record showing the reversible membrane depolarization
and increased frequency of spontaneous action potentials in a neuron
treated with C-Ag200.
(B) Increase in mean frequency of spontaneous action potentials of
individual neurons in normal saline followed by C-Ag200 (p < 0.02,
Wilcoxon signed-rank test).
(C) Bath application of C-Ag15 results in a reversible decrease in the
frequency of spontaneous action potentials. Slight hyperpolarization
of the resting membrane potential is also apparent.
(D) The mean frequency of action potentials in individual neurons is
consistently reduced by treatment with C-Ag15 (p < 0.001, Wilcoxon
signed-rank test).the identity of the receptor (or receptors) on neurons that
binds agrin. The results presented here show that agrin
acts as an endogenous ouabain-like molecule targeted
specifically to the a3NKA, a member of the NKA family se-
lectively expressed in neurons. NKAs are responsible for
Figure 6. Neuronal Activity In Vivo Is Regulated by Endoge-
nous Agrin-a3NKA Interactions
(A) Detergent-solubilized membranes of BS3-crosslinked cultured cor-
tical neurons or cortical slice were immunoprecipitated (IP) with anti-
bodies against either agrin (Ag) or the a3NKA (a3) and then immuno-
blotted for a3NKA. BS3 crosslinking of either cultured neurons or
cortex results in the formation of an 300 kDa adduct, indicative of
the presence of native agrin-a3NKA complexes. Endogenous agrin-
a3NKA interactions can be disrupted by incubation with C-Ag15, re-
sulting in the appearance of a 125 kDa C-Ag15-a3NKA band. For com-
parison, the 110 kDa a3NKA visualized by immunoprecipitation and
immunoblotting with the same a3NKA antibody in the absence of
crosslinking is shown.
(B) A whole-cell current-clamp record from layer V neuron in a slice of
motor cortex. Treatment with agrin results in reversible membrane de-
polarization and appearance of high-frequency action potentials.
(C) The mean action potential frequency of individual neurons was sig-
nificantly increased by treatment with C-Ag200 (p < 0.01, Wilcoxon
signed-rank test).
(D) A typical current-clamp record showing action potentials induced
by treatment with kainic acid (K). Addition of C-Ag15 results in revers-
ible membrane repolarization and blockade of action potentials.
(E) C-Ag15 consistently inhibited firing of kainate-induced action po-
tentials in individual neurons (p < 0.01, Wilcoxon signed-rank test).Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc. 365
Figure 7. Model of Agrin Function at the Synapse
The resting Na+/K+ electrochemical gradient depends on activity of local a3NKAs; some a3NKAs are bound to and inhibited by agrin at rest. Further
inhibition of a3NKAs by agrin results in collapse of the Na+ gradient within a diffusion-restricted physiological space, leading to slowing or even
reversal of the NCX and a rapid rise in cytoplasmic Ca2+ concentration. Depolarization of synaptic membranes associated with the increase in intra-
cellular Na+ concentration following a3NKA inhibition also triggers Ca2+ influx through voltage-gated channels. Increased cytoplasmic Ca2+, aug-
mented by Ca2+-induced Ca2+ release from intracellular stores via ryanodine receptors (Hilgenberg and Smith, 2004), activates CaMKII and other
Ca2+ effectors known to regulate a variety of synaptic functions such as neurotransmitter release and neurotransmitter receptor turnover. Agrin
and the a3NKA are shown on both pre- and postsynaptic membranes; however their precise subcellular location remains to be determined.maintaining the Na+/K+ ion gradient that underlies the
membrane potential and provides the driving force for a
variety of secondary cellular processes necessary for nor-
mal cell function. Whereas studies of a3NKA mutant mice
will be needed to determine whether additional agrin re-
ceptors are present in neural tissues, the results of these
experiments indicate that many of agrin’s effects in neu-
rons are driven by local and/or global changes in the
Na+/K+ ion gradient.
An early response to agrin is an increase in cytoplasmic
Ca2+, a composite of Ca2+ release from intracellular stores
and influx through voltage-gated channels (Hilgenberg
and Smith, 2004). The finding that agrin antagonizes the
a3NKA provides a simple explanation for these obser-
vations (see model, Figure 7). It is well known that the
plasma-membrane sodium/calcium exchanger (NCX)
plays a key role in Ca2+ homeostasis. However, because
of its dependence on the Na+ ion gradient, activity of the
NCX is largely governed by the NKA: Under normal condi-
tions, the pump operates in forward mode, transporting
Ca2+ ions out of the cell, but the direction of transport re-
verses as the Na+ ion gradient declines (Annunziato et al.,
2004). In neurons, the a3NKA and NCX colocalize within
plasma-membrane domains, juxtaposed by elements of
the endoplasmic reticulum, creating a diffusion-restricted366 Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc.cytoplasmic space that enhances the functional linkage
between them (Blaustein et al., 2002). Thus, one compo-
nent of the agrin-induced increase in intracellular Ca2+ is
likely to be due to changes in NCX activity driven by inhi-
bition of the a3NKA, a hypothesis that could be tested by
examining the agrin response of NCX mutant neurons.
Whereas we previously speculated that an agrin-induced
membrane conductance might be responsible for Ca2+
influx through voltage-gated channels, the model sug-
gests that opening of voltage-gated Ca2+ channels in re-
sponse to membrane depolarization associated with the
agrin-induced decline in a3NKA activity is more likely.
The present study provides strong evidence for a role for
agrin in regulating neuronal activity. Action potential fre-
quencies were dramatically increased by exogenous
agrin; more importantly, C-Ag15, an agrin fragment that
acts as an agrin antagonist, disrupted native agrin-
a3NKA interactions, blocking spontaneous action poten-
tials in bothculturedneuronsandacute-slicepreparations.
Agrin behaves as an endogenous ouabain-like molecule,
and mechanisms of ouabain-induced hyperexcitability
have been studied in hippocampal neurons, where
changes in both intrinsicmembrane properties and synap-
tic transmission are important (Vaillend et al., 2002). Neu-
rons express multiple NKA subunits, and, given agrin’s
exquisite specificity for the a3NKA, only a subset of the
effects attributed to ouabain may be agrin dependent.
Nevertheless, the observation that agrin and its receptor
are concentrated at synapses suggests the synapse is
an important site of agrin action. Neurotransmitter release
and/or spike threshold are both dependent on membrane
potential; functional coupling between the a3NKA and
NCX, which plays a role in vesicle cycling and neurotrans-
mitter release (Bouron and Reuter, 1996), may also be im-
portant. Consistent with the latter possibility, suppression
of agrin expression in cultured hippocampal neurons is as-
sociated with a decrease in synaptic vesicle cycling (Bo¨se
et al., 2000). Not surprisingly, behavioral studies have
shown that ouabain inhibits memory formation (Gibbs
andNg, 1978; Xia et al., 1997; Sato et al., 2004), while a de-
cline in NKA activity is responsible for a form of long-term
plasticity in hippocampal interneurons (Ross and Soltesz,
2001). Agrin expression is activity dependent (O’Connor
et al., 1995), and it is tempting to speculate that agrin reg-
ulation of thea3NKAmight play a role in synaptic plasticity.
Given the functional link between the a3NKA and NCX,
studies showing enhanced learning and memory in mice
lacking NCX2 (Jeon et al., 2003) support this hypothesis.
Clearly, more detailed studies of the spatiotemporal
changes in agrin expression and the effects of conditional
knockouts of agrin and thea3NKAon learning andmemory
are required.
Dysfunction of the a3NKA has been strongly linked with
pathological changes in the brain. Intraventricular infusion
of ouabain causes seizures (Davidson et al., 1978), and
loss of a3NKA activity potentiates excitotoxic injury and
neuronal-cell death (Brines et al., 1995; Xiao et al., 2002).
In addition, mutation of the a3NKA has been shown to be
responsible for rapid-onset dystonia parkinsonism, an au-
tosomal-dominant movement disorder in human (de Car-
valho Aguiar et al., 2004). Paralleling these observations,
heterozygous agrin-deficient mice are less sensitive to
kainic acid than their wild-type siblings, while agrin-defi-
cient neurons exhibit decreased responses to excitatory
stimuli and resistance to excitotoxic insult (Hilgenberg
et al., 2002). Interestingly, these effects of mutating the
Agrn gene are predicted by our model: Decreased agrin
expression, functionally equivalent to treatment with C-
Ag15, translates into an increase in total a3NKA activity
that lowers neuronal activity while enhancing the ability
to buffer potentially damaging increases in intracellular
Ca2+ ions by sustaining activity of the NCX. Together,
these studies suggest that dysregulation of agrin expres-
sion will have a significant impact on brain function. It is
noteworthy that agrin is concentrated in both amyloid
plaques and tangles characteristic of Alzheimer’s disease
(Verbeeketal., 1999) andLewybodies found inParkinson’s
disease (Liu et al., 2005) and may, therefore, contribute to
the etiology of these diseases. The ability of C-Ag15 to re-
lieve inhibition of the a3NKA by endogenous agrin sug-
gests that it will be a useful starting point for the develop-
ment of therapeutic agents that might alleviate or reverse
the progress of these and other diseases of the CNS.Agrin was originally identified at the neuromuscular
junction, where it mediates the motor neuron-induced ac-
cumulation of AChR in the postsynaptic muscle-fiber
membrane. Curiously, agrin molecules present at the
junction are functionally heterogeneous and distinct in cel-
lular origin: Alternatively spliced z+ isoforms, equivalent to
C-Ag908 and C-Ag208, have high AChR clustering activity
and originate from motor neurons; z0 agrin, like C-Ag200,
has no AChR clustering activity and is synthesized by
muscle (Sanes and Lichtman, 2001). The function of z0
agrin is unclear, but its location and origin are consistent
with a role as a retrograde signal agent. The fact that the
a3NKA is expressed on motor neuron axon terminals
(Zahler et al., 1996) suggests it may be the target for mus-
cle agrin. Possible roles for this retrograde signal would in-
clude tuning neurotransmitter release to themuscle fiber’s
action potential threshold or matching growth of the axon
terminal to themuscle fiber. Further studies will be needed
to examine the effects of agrin on synaptic transmission at
the neuromuscular junction. However, guidance of devel-
oping axons is known to depend on translation of local
cues to changes in intracellular Ca2+ within the growth
cone (Zheng, 2000), which is also a site of a3NKA concen-
tration (Brines and Robbins, 1993). Thus, agrin regulation
of a3NKA provides an attractive explanation for the obser-
vation that motor neurons overgrow their target muscle in
agrin mutant mice (Gautam et al., 1996) and that z0 agrin
inhibits growth and stimulates axon-terminal differentia-
tion in cultured neurons (Campagna et al., 1997).
Finally, because of its positive inotropic effect, themajor
therapeutic use of ouabain and related compounds is in
the treatment of congestive heart failure. Although cardiac
muscle expresses multiple NKA isoforms, the low effec-
tive dose of ouabain suggests that its therapeutic effects
aremediated by the high-affinity a2- and a3NKAs (Glitsch,
2001). Agrin, which acts as an endogenous ouabain, is
also expressed in heart (Godfrey et al., 1988; Hoch
et al., 1993). While a role for agrin in heart function remains
to be determined, understanding the structural basis of
agrin’s specificity for a single member of a family of such
closely related proteins and the mechanisms by which it
regulates a3NKA function is likely to contribute to the un-
derstanding and development of improved therapies for
cardiac disease.
EXPERIMENTAL PROCEDURES
Cell Culture
Primary cultures of mouse 1- to 2-day postnatal cortical neurons were
prepared as described (Hilgenberg et al., 1999; Hilgenberg and Smith,
2004). Experiments were performed between 10 and 16 days in cul-
ture.
Nonneuronal cells were prepared by growing dissociated rat cortical
cells in minimal essential medium supplemented with 10% fetal bovine
serum. Contaminating neurons were removed by treating the cultures
briefly with 0.5% trypsin, and the cells were resuspended by trituration
followed by dilution and replating. No neurons were detectable follow-
ing two replatings, as indicated by staining with a MAP-2 antibody
(SMI-52, Sternberger Monoclonals).Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc. 367
All handling and treatment of animals complied with the guidelines
of the Institutional Animal Care and Use Committee of the University
of California, Irvine.
Immunohistochemistry
Neuronal and nonneuronal cells were identified by double staining with
a mouse antibody directed against MAP-2 and a rabbit antibody
against GFAP (DAKO) as described (Hilgenberg et al., 1999). Agrin
binding sites and a3NKA were visualized by double labeling with
C-Ag208 (Hoover et al., 2003) and monoclonal antibody XVIF9-G10
(Novus Biologicals) against the a3NKA (see Supplemental Data for de-
tails). The concentration of agrin used here and in other parts of the
study was based on bioactivity determined by Ca2+ imaging of agrin-
induced increases in intracellular Ca2+ in cultured cortical neurons (Hil-
genberg and Smith, 2004).
Biochemistry
Membrane-impermeant chemical crosslinking agents BS3 and DMA
(Pierce) were used to stabilize the bond between agrin and its binding
sites on cell surface membranes. Cultured neurons were washed
briefly in phosphate-buffered saline (PBS) containing 10 mM EDTA fol-
lowed by preincubation with one or more agrin fragment in PBS con-
taining 1.8 mM Ca2+ for 30 min at room temperature and then cooled
on ice prior to addition of a 10 solution of crosslinking agent to a final
concentration of 0.1mM. The crosslinking reactionwas allowed to pro-
ceed for 30 min, after which any unreacted crosslinker was quenched
and removed by washing with ice-cold PBS2+ containing 50 mM eth-
anolamine. For immunoblot analysis, cells were scraped into ice-
cold TI buffer (20 mM Tris [pH 7.4], 10 mM EDTA, and protease inhib-
itors [Sigma, P8340]) and then Dounce homogenized, and membrane
fractions were recovered by centrifugation. For immunoprecipitation
studies, cells were scraped and homogenized in TI buffer containing
150 mM NaCl and 0.5% Triton X-100. Cell extracts were cleared by
centrifugation, and aliquots of the detergent-soluble fraction were
incubated with the appropriate antibody at 4ºC overnight. Antigen-
antibody complexes were precipitated with either protein A or protein
G and resuspended in SDS-PAGE sample buffer for immunoblot anal-
ysis.
Na+ Imaging
Intracellular Na+ was monitored by ratiometric imaging of the mem-
brane-permeant sodium binding fluorescent dye SBFI-AM (Molecular
Probes) by essentially the samemethods described for Fura-2 imaging
of agrin-induced changes in neuronal Ca2+ (Hilgenberg and Smith,
2004). For quantitative analyses, responses of individual cells were
normalized to their maximal response to treatment with 5 mM gramici-
din, a potent ionophore.
Electrophysiology
Standard whole-cell current-clamp techniques were used to measure
membrane potentials and spontaneous action potentials in cortical
neurons in culture and acutely prepared slices (see Supplemental
Data for details). Only neurons with stable pretreatment resting poten-
tials of55mVor less that also exhibited a reversible response to agrin
or ouabain were accepted for analysis. Action potential frequency
measurements were performed on 3–5 min of data during each phase
(pretreatment, treatment, posttreatment) of the experiment. All record-
ings were carried out at room temperature.
Expression Studies
The plasmid pRca3-AAC (a generous gift of J. Lingrel and T. Pressley)
encodes an ouabain-insensitive rat a3 subunit of the NKA when ex-
pressed in eukaryotic cells. To generate a wild-type a3 expression
construct, an 805 bp SacII/Bsu36I restriction fragment was excised
from pRca3-AAC and replaced with the corresponding fragment iso-
lated by RT-PCR from rat brain RNA to form pRca3 used for expres-
sion of the native a3NKA subunit. Nonneuronal cells prepared from368 Cell 125, 359–369, April 21, 2006 ª2006 Elsevier Inc.rat or mouse cortex were cotransfected with pRca3 and the enhanced
green fluorescent protein vector pEGFP-C1 (Clontech) to facilitate
identification of transfected cells using the Effectene reagent (QIAGEN)
according to the manufacturer’s instructions. Agrin responses of non-
neuronal cells were determined by Na+ imaging and whole-cell cur-
rent-clamp as for cultured neurons.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and can be found with this article online at http://www.cell.com/cgi/
content/full/125/2/359/DC1/.
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